https://stock.noler.com/us/stock/nvax https://stock.noler.com/us/stock/nvax/roast-me https://stock.noler.com/us/stock/nvax/market-cap https://stock.noler.com/us/stock/nvax/pe-ratio https://stock.noler.com/us/stock/nvax/ps-ratio https://stock.noler.com/us/stock/nvax/price-book-ratio https://stock.noler.com/us/stock/nvax/dividend-yield https://stock.noler.com/us/stock/nvax/stock-splits https://stock.noler.com/us/stock/nvax/profit-margins https://stock.noler.com/us/stock/nvax/current-ratio https://stock.noler.com/us/stock/nvax/quick-ratio https://stock.noler.com/us/stock/nvax/roe https://stock.noler.com/us/stock/nvax/roa https://stock.noler.com/us/stock/nvax/return-tang-equity https://stock.noler.com/us/stock/nvax/key-financial-ratios https://stock.noler.com/us/stock/nvax/employee-count https://stock.noler.com/us/stock/nvax/insider-transactions https://stock.noler.com/us/stock/nvax/graph https://stock.noler.com/us/stock/nvax/revenue-breakdown https://stock.noler.com/us/stock/nvax/expense-breakdown https://stock.noler.com/us/stock/nvax/cash-flow-breakdown https://stock.noler.com/us/stock/nvax/cash-on-hand https://stock.noler.com/us/stock/nvax/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/nvax/marketable-securities-current https://stock.noler.com/us/stock/nvax/inventory-finished-goods https://stock.noler.com/us/stock/nvax/inventory-work-in-process https://stock.noler.com/us/stock/nvax/inventory-valuation-reserves https://stock.noler.com/us/stock/nvax/inventory-net https://stock.noler.com/us/stock/nvax/supplies https://stock.noler.com/us/stock/nvax/other-assets-current https://stock.noler.com/us/stock/nvax/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/nvax/assets-current https://stock.noler.com/us/stock/nvax/operating-lease-right-of-use-asset https://stock.noler.com/us/stock/nvax/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/nvax/leasehold-improvements-gross https://stock.noler.com/us/stock/nvax/property-plant-and-equipment-gross https://stock.noler.com/us/stock/nvax/accumulated-depreciation-depletion-and-amortization-property-plant-and-equipment https://stock.noler.com/us/stock/nvax/property-plant-and-equipment-net https://stock.noler.com/us/stock/nvax/goodwill https://stock.noler.com/us/stock/nvax/other-assets-noncurrent https://stock.noler.com/us/stock/nvax/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/nvax/total-assets https://stock.noler.com/us/stock/nvax/accounts-receivable-gross https://stock.noler.com/us/stock/nvax/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/nvax/accounts-receivable-net https://stock.noler.com/us/stock/nvax/debt-securities-available-for-sale-amortized-cost-excluding-accrued-interest-before-allowance-for-credit-loss https://stock.noler.com/us/stock/nvax/debt-securities-available-for-sale-excluding-accrued-interest https://stock.noler.com/us/stock/nvax/unbilled-contracts-receivable https://stock.noler.com/us/stock/nvax/billed-contract-receivables https://stock.noler.com/us/stock/nvax/debt-securities-available-for-sale-continuous-unrealized-loss-position12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/nvax/available-for-sale-debt-securities-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/nvax/available-for-sale-debt-securities-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/nvax/inventory-raw-materials https://stock.noler.com/us/stock/nvax/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/nvax/goodwill-written-off-related-to-sale-of-business-unit https://stock.noler.com/us/stock/nvax/capitalized-contract-cost-accumulated-amortization https://stock.noler.com/us/stock/nvax/employee-service-share-based-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/nvax/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/nvax/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/nvax/deferred-tax-assets-tax-credit-carryforwards-foreign https://stock.noler.com/us/stock/nvax/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-share-based-compensation-cost https://stock.noler.com/us/stock/nvax/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/nvax/deferred-tax-assets-inventory https://stock.noler.com/us/stock/nvax/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/nvax/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/nvax/deferred-tax-assets-other https://stock.noler.com/us/stock/nvax/deferred-tax-assets-gross https://stock.noler.com/us/stock/nvax/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nvax/deferred-tax-assets-net https://stock.noler.com/us/stock/nvax/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/nvax/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/nvax/noncurrent-assets https://stock.noler.com/us/stock/nvax/investment-company-average-net-assets https://stock.noler.com/us/stock/nvax/accounts-payable-current https://stock.noler.com/us/stock/nvax/employee-related-liabilities-current https://stock.noler.com/us/stock/nvax/accrued-liabilities-current https://stock.noler.com/us/stock/nvax/contract-with-customer-liability-current https://stock.noler.com/us/stock/nvax/finance-lease-liability-current https://stock.noler.com/us/stock/nvax/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/nvax/other-liabilities-current https://stock.noler.com/us/stock/nvax/customer-refund-liability-current https://stock.noler.com/us/stock/nvax/liabilities-current https://stock.noler.com/us/stock/nvax/convertible-long-term-notes-payable https://stock.noler.com/us/stock/nvax/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/nvax/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/nvax/other-liabilities-noncurrent https://stock.noler.com/us/stock/nvax/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/nvax/total-liabilities https://stock.noler.com/us/stock/nvax/contract-with-customer-liability https://stock.noler.com/us/stock/nvax/operating-lease-liability https://stock.noler.com/us/stock/nvax/convertible-notes-payable https://stock.noler.com/us/stock/nvax/long-term-debt https://stock.noler.com/us/stock/nvax/finance-lease-liability https://stock.noler.com/us/stock/nvax/debt-instrument-unamortized-discount https://stock.noler.com/us/stock/nvax/debt-instrument-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/nvax/deferred-revenue https://stock.noler.com/us/stock/nvax/other-accrued-liabilities-current https://stock.noler.com/us/stock/nvax/loss-contingency-accrual-at-carrying-value https://stock.noler.com/us/stock/nvax/loss-contingency-accrual-carrying-value-current https://stock.noler.com/us/stock/nvax/loss-contingency-new-claims-filed-number https://stock.noler.com/us/stock/nvax/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/nvax/finance-lease-liability-payments-due https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-due https://stock.noler.com/us/stock/nvax/other-sundry-liabilities-current https://stock.noler.com/us/stock/nvax/other-sundry-liabilities-noncurrent https://stock.noler.com/us/stock/nvax/deferred-income-tax-liabilities https://stock.noler.com/us/stock/nvax/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/nvax/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/nvax/deferred-tax-liabilities https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits-increases-resulting-from-prior-period-tax-positions https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits-decreases-resulting-from-prior-period-tax-positions https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits-increases-resulting-from-current-period-tax-positions https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/nvax/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/nvax/operating-lease-liability-current https://stock.noler.com/us/stock/nvax/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/nvax/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/nvax/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/nvax/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/nvax/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/nvax/preferred-stock-value https://stock.noler.com/us/stock/nvax/common-stock-value https://stock.noler.com/us/stock/nvax/additional-paid-in-capital https://stock.noler.com/us/stock/nvax/treasury-stock-common-value https://stock.noler.com/us/stock/nvax/accumulated-other-comprehensive-income-loss-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/nvax/accumulated-other-comprehensive-income-loss-net-of-tax https://stock.noler.com/us/stock/nvax/retained-earnings-accumulated-deficit https://stock.noler.com/us/stock/nvax/share-holder-equity https://stock.noler.com/us/stock/nvax/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nvax/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nvax/preferred-stock-shares-issued https://stock.noler.com/us/stock/nvax/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/nvax/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nvax/common-stock-shares-authorized https://stock.noler.com/us/stock/nvax/common-stock-shares-issued https://stock.noler.com/us/stock/nvax/common-stock-shares-outstanding https://stock.noler.com/us/stock/nvax/treasury-stock-common-shares https://stock.noler.com/us/stock/nvax/employee-service-share-based-compensation-nonvested-awards-total-compensation-cost-not-yet-recognized https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/nvax/sharebased-compensation-arrangement-by-sharebased-payment-award-options-exercisable-intrinsic-value1 https://stock.noler.com/us/stock/nvax/dei-entity-common-stock-shares-outstanding https://stock.noler.com/us/stock/nvax/dei-entity-public-float https://stock.noler.com/us/stock/nvax/liabilities-and-stockholders-equity https://stock.noler.com/us/stock/nvax/revenues https://stock.noler.com/us/stock/nvax/revenue https://stock.noler.com/us/stock/nvax/operating-income https://stock.noler.com/us/stock/nvax/gain-loss-on-disposition-of-assets1 https://stock.noler.com/us/stock/nvax/investment-income-interest https://stock.noler.com/us/stock/nvax/other-nonoperating-income-expense https://stock.noler.com/us/stock/nvax/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/nvax/translation-adjustment-functional-to-reporting-currency-gain-loss-reclassified-to-earnings-net-of-tax https://stock.noler.com/us/stock/nvax/income-loss-from-continuing-operations-before-income-taxes-extraordinary-items-noncontrolling-interest https://stock.noler.com/us/stock/nvax/income-loss-from-continuing-operations-before-income-taxes-domestic https://stock.noler.com/us/stock/nvax/income-loss-from-continuing-operations-before-income-taxes-foreign https://stock.noler.com/us/stock/nvax/net-income https://stock.noler.com/us/stock/nvax/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/nvax/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/nvax/other-comprehensive-income-loss-net-of-tax-portion-attributable-to-parent https://stock.noler.com/us/stock/nvax/comprehensive-income-net-of-tax https://stock.noler.com/us/stock/nvax/other-comprehensive-income-foreign-currency-transaction-and-translation-adjustment-net-of-tax-portion-attributable-to-parent https://stock.noler.com/us/stock/nvax/other-comprehensive-income-loss-available-for-sale-securities-adjustment-net-of-tax https://stock.noler.com/us/stock/nvax/other-comprehensive-income-availableforsale-securities-adjustment-net-of-tax-portion-attributable-to-parent https://stock.noler.com/us/stock/nvax/earnings-per-share-basic https://stock.noler.com/us/stock/nvax/weighted-average-number-of-shares-outstanding-basic https://stock.noler.com/us/stock/nvax/eps https://stock.noler.com/us/stock/nvax/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/nvax/weighted-average-number-of-diluted-shares-outstanding https://stock.noler.com/us/stock/nvax/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/nvax/cost-of-revenue https://stock.noler.com/us/stock/nvax/inventory-write-down https://stock.noler.com/us/stock/nvax/restructuring-charges https://stock.noler.com/us/stock/nvax/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/nvax/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/nvax/operating-lease-cost https://stock.noler.com/us/stock/nvax/variable-lease-cost https://stock.noler.com/us/stock/nvax/lease-cost https://stock.noler.com/us/stock/nvax/inventory-firm-purchase-commitment-loss https://stock.noler.com/us/stock/nvax/research-and-development-expense https://stock.noler.com/us/stock/nvax/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/nvax/depreciation-and-amortization https://stock.noler.com/us/stock/nvax/goodwill-impairment-loss https://stock.noler.com/us/stock/nvax/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/nvax/asset-impairment-charges https://stock.noler.com/us/stock/nvax/advertising-expense https://stock.noler.com/us/stock/nvax/general-and-administrative-expense https://stock.noler.com/us/stock/nvax/selling-general-and-administrative-expense https://stock.noler.com/us/stock/nvax/costs-and-expenses https://stock.noler.com/us/stock/nvax/capitalized-contract-cost-amortization https://stock.noler.com/us/stock/nvax/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/nvax/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/nvax/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/nvax/interest-expense-debt https://stock.noler.com/us/stock/nvax/finance-lease-interest-expense https://stock.noler.com/us/stock/nvax/interest-expense-nonoperating https://stock.noler.com/us/stock/nvax/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-cross-border-other-amount https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-cross-border-other-percent https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-continuing-operations https://stock.noler.com/us/stock/nvax/income-tax-expense-benefit https://stock.noler.com/us/stock/nvax/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/nvax/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/nvax/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/nvax/current-income-tax-expense-benefit https://stock.noler.com/us/stock/nvax/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/nvax/federal-state-and-local-income-tax-expense-benefit-continuing-operations https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-income-tax-expense-benefit-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/nvax/income-tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/nvax/net-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/nvax/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/nvax/depreciation-depletion-and-amortization https://stock.noler.com/us/stock/nvax/share-based-compensation https://stock.noler.com/us/stock/nvax/other-noncash-income-expense https://stock.noler.com/us/stock/nvax/increase-decrease-in-inventories https://stock.noler.com/us/stock/nvax/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/nvax/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/nvax/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/nvax/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nvax/net-cash-provided-by-used-in-investing-activities https://stock.noler.com/us/stock/nvax/proceeds-from-sale-of-other-productive-assets https://stock.noler.com/us/stock/nvax/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/nvax/proceeds-from-maturities-prepayments-and-calls-of-available-for-sale-securities https://stock.noler.com/us/stock/nvax/proceeds-from-sale-of-property-held-for-sale https://stock.noler.com/us/stock/nvax/payments-to-acquire-available-for-sale-securities-debt https://stock.noler.com/us/stock/nvax/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/nvax/net-cash-provided-by-used-in-financing-activities https://stock.noler.com/us/stock/nvax/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/nvax/proceeds-from-convertible-debt https://stock.noler.com/us/stock/nvax/proceeds-from-issuance-of-common-stock https://stock.noler.com/us/stock/nvax/payments-for-capital-improvements https://stock.noler.com/us/stock/nvax/payments-for-software https://stock.noler.com/us/stock/nvax/repayments-of-convertible-debt https://stock.noler.com/us/stock/nvax/finance-lease-principal-payments https://stock.noler.com/us/stock/nvax/cash-cash-equivalents-restricted-cash-and-restricted-cash-equivalents-period-increase-decrease-including-exchange-rate-effect https://stock.noler.com/us/stock/nvax/effect-of-exchange-rate-on-cash-cash-equivalents-restricted-cash-and-restricted-cash-equivalents https://stock.noler.com/us/stock/nvax/cash-cash-equivalents-restricted-cash-and-restricted-cash-equivalents https://stock.noler.com/us/stock/nvax/cash-cash-equivalents-restricted-cash-and-restricted-cash-equivalents-disposal-group-including-discontinued-operations https://stock.noler.com/us/stock/nvax/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/nvax/notes-issued1 https://stock.noler.com/us/stock/nvax/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/nvax/operating-lease-payments https://stock.noler.com/us/stock/nvax/ecd-non-peo-neo-avg-comp-actually-paid-amt https://stock.noler.com/us/stock/nvax/ecd-peo-actually-paid-comp-amt https://stock.noler.com/us/stock/nvax/interest-paid-net https://stock.noler.com/us/stock/nvax/income-tax-paid-federal-after-refund-received https://stock.noler.com/us/stock/nvax/income-tax-paid-state-and-local-after-refund-received https://stock.noler.com/us/stock/nvax/income-taxes-paid-net https://stock.noler.com/us/stock/nvax/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/nvax/adjustments-to-additional-paid-in-capital-stock-issued-issuance-costs https://stock.noler.com/us/stock/nvax/adjustments-to-additional-paid-in-capital-sharebased-compensation-requisite-service-period-recognition-value https://stock.noler.com/us/stock/nvax/number-of-reporting-units https://stock.noler.com/us/stock/nvax/litigation-settlement-amount-awarded-from-other-party https://stock.noler.com/us/stock/nvax/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/nvax/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/nvax/number-of-reportable-segments https://stock.noler.com/us/stock/nvax/number-of-operating-segments https://stock.noler.com/us/stock/nvax/segment-reporting-other-item-amount https://stock.noler.com/us/stock/nvax/ecd-co-selected-measure-amt https://stock.noler.com/us/stock/nvax/ffd-net-fee-amt https://stock.noler.com/us/stock/nvax/ecd-non-peo-neo-avg-total-comp-amt https://stock.noler.com/us/stock/nvax/ecd-peer-group-total-shareholder-rtn-amt https://stock.noler.com/us/stock/nvax/ecd-peo-total-comp-amt https://stock.noler.com/us/stock/nvax/ecd-total-shareholder-rtn-amt https://stock.noler.com/us/stock/nvax/ffd-ttl-fee-amt https://stock.noler.com/us/stock/nvax/ffd-ttl-offering-amt https://stock.noler.com/us/stock/nvax/ffd-ttl-offset-amt https://stock.noler.com/us/stock/nvax/cash https://stock.noler.com/us/stock/nvax/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/nvax/accounts-receivable-net-current https://stock.noler.com/us/stock/nvax/unbilled-receivables-current https://stock.noler.com/us/stock/nvax/receivables-net-current https://stock.noler.com/us/stock/nvax/other-prepaid-expense-current https://stock.noler.com/us/stock/nvax/prepaid-expense-current https://stock.noler.com/us/stock/nvax/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/nvax/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/nvax/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/nvax/available-for-sale-securities-debt-securities https://stock.noler.com/us/stock/nvax/available-for-sale-securities-debt-maturities-next-rolling-twelve-months-amortized-cost-basis https://stock.noler.com/us/stock/nvax/available-for-sale-securities-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/nvax/debt-securities-available-for-sale-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/nvax/debt-securities-available-for-sale-unrealized-loss-position https://stock.noler.com/us/stock/nvax/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/nvax/available-for-sale-securities https://stock.noler.com/us/stock/nvax/available-for-sale-securities-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/nvax/available-for-sale-securities-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/nvax/available-for-sale-securities-amortized-cost https://stock.noler.com/us/stock/nvax/available-for-sale-securities-continuous-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/nvax/available-for-sale-securities-current https://stock.noler.com/us/stock/nvax/available-for-sale-securities-fair-value-disclosure https://stock.noler.com/us/stock/nvax/availableforsale-securities-gross-unrealized-gain https://stock.noler.com/us/stock/nvax/available-for-sale-securities-noncurrent https://stock.noler.com/us/stock/nvax/municipal-debt-securities-at-carrying-value https://stock.noler.com/us/stock/nvax/available-for-sale-debt-securities-amortized-cost-basis https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/nvax/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/nvax/goodwill-acquired-during-period https://stock.noler.com/us/stock/nvax/goodwill-translation-and-purchase-accounting-adjustments https://stock.noler.com/us/stock/nvax/goodwill-translation-adjustments https://stock.noler.com/us/stock/nvax/increase-decrease-in-unbilled-receivables https://stock.noler.com/us/stock/nvax/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/nvax/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/nvax/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/nvax/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/nvax/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nvax/deferred-tax-assets-tax-credit-carryforwards-alternative-minimum-tax https://stock.noler.com/us/stock/nvax/deferred-tax-assets-tax-credit-carryforwards-other https://stock.noler.com/us/stock/nvax/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-cash-and-equivalents https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-current-assets-receivables https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-current-assets-other https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-property-plant-and-equipment https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-noncurrent-liabilities-other https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/nvax/government-contract-receivable https://stock.noler.com/us/stock/nvax/fair-value-assets-level1-to-level2-transfers-amount https://stock.noler.com/us/stock/nvax/fair-value-assets-level2-to-level1-transfers-amount https://stock.noler.com/us/stock/nvax/government-contract-receivable-unbilled-amounts https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-receivable https://stock.noler.com/us/stock/nvax/deferred-revenue-current https://stock.noler.com/us/stock/nvax/short-term-borrowings https://stock.noler.com/us/stock/nvax/convertible-notes-payable-current https://stock.noler.com/us/stock/nvax/notes-payable-current https://stock.noler.com/us/stock/nvax/deferred-rent-credit-current https://stock.noler.com/us/stock/nvax/derivative-liabilities-current https://stock.noler.com/us/stock/nvax/interest-payable-current https://stock.noler.com/us/stock/nvax/long-term-notes-payable https://stock.noler.com/us/stock/nvax/deferred-revenue-noncurrent https://stock.noler.com/us/stock/nvax/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/nvax/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/nvax/commitments-and-contingencies https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/nvax/restructuring-reserve https://stock.noler.com/us/stock/nvax/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/nvax/loss-contingency-damages-sought-value https://stock.noler.com/us/stock/nvax/loss-contingency-number-of-defendants https://stock.noler.com/us/stock/nvax/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/nvax/purchase-obligation https://stock.noler.com/us/stock/nvax/debt-instrument-carrying-amount https://stock.noler.com/us/stock/nvax/debt-instrument-face-amount https://stock.noler.com/us/stock/nvax/debt-instrument-interest-rate-stated-percentage https://stock.noler.com/us/stock/nvax/debt-instrument-interest-rate-effective-percentage https://stock.noler.com/us/stock/nvax/debt-instrument-interest-rate-during-period https://stock.noler.com/us/stock/nvax/debt-instrument-basis-spread-on-variable-rate1 https://stock.noler.com/us/stock/nvax/debt-instrument-periodic-payment https://stock.noler.com/us/stock/nvax/debt-instrument-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/nvax/debt-instrument-decrease-forgiveness https://stock.noler.com/us/stock/nvax/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/nvax/debt-instrument-basis-spread-on-variable-rate https://stock.noler.com/us/stock/nvax/debt-instrument-increase-additional-borrowings https://stock.noler.com/us/stock/nvax/debt-instrument-interest-rate-stated-percentage-rate-range-minimum https://stock.noler.com/us/stock/nvax/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/nvax/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/nvax/deferred-tax-liabilities-other https://stock.noler.com/us/stock/nvax/unrecognized-tax-benefits-increases-resulting-from-settlements-with-taxing-authorities https://stock.noler.com/us/stock/nvax/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-current-liabilities-accounts-payable https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-noncurrent-liabilities-long-term-debt https://stock.noler.com/us/stock/nvax/business-combination-recognized-identifiable-assets-acquired-and-liabilities-assumed-capital-lease-obligation https://stock.noler.com/us/stock/nvax/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/nvax/fair-value-measurement-with-unobservable-inputs-reconciliation-recurring-basis-liability-period-increase-decrease https://stock.noler.com/us/stock/nvax/fair-value-liabilities-level1-to-level2-transfers-amount https://stock.noler.com/us/stock/nvax/fair-value-liabilities-level2-to-level1-transfers-amount https://stock.noler.com/us/stock/nvax/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/nvax/capital-lease-obligations-current https://stock.noler.com/us/stock/nvax/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-due-in-rolling-after-year-five https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/nvax/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/nvax/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/nvax/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/nvax/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/nvax/temporary-equity-shares-authorized https://stock.noler.com/us/stock/nvax/temporary-equity-shares-issued https://stock.noler.com/us/stock/nvax/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/nvax/treasury-stock-value https://stock.noler.com/us/stock/nvax/receivable-from-officers-and-directors-for-issuance-of-capital-stock https://stock.noler.com/us/stock/nvax/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/nvax/shares-issued-price-per-share https://stock.noler.com/us/stock/nvax/stockholders-equity-note-stock-split-conversion-ratio1 https://stock.noler.com/us/stock/nvax/common-stock-convertible-conversion-price-increase https://stock.noler.com/us/stock/nvax/sale-of-stock-price-per-share https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-nonvested-number https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-grants-in-period https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-vested-in-period https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-forfeited-in-period https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-nonvested-weighted-average-grant-date-fair-value https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/nvax/business-combination-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/nvax/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/nvax/treasury-stock-shares https://stock.noler.com/us/stock/nvax/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/nvax/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/nvax/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/nvax/investment-income-net https://stock.noler.com/us/stock/nvax/other-nonoperating-income https://stock.noler.com/us/stock/nvax/income-loss-from-continuing-operations-before-income-taxes-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/nvax/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/nvax/other-comprehensive-income-unrealized-holding-gain-loss-on-securities-arising-during-period-net-of-tax https://stock.noler.com/us/stock/nvax/marketable-securities-realized-gain-loss https://stock.noler.com/us/stock/nvax/contract-with-customer-liability-revenue-recognized https://stock.noler.com/us/stock/nvax/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/nvax/available-for-sale-securities-gross-unrealized-gains https://stock.noler.com/us/stock/nvax/contracts-revenue https://stock.noler.com/us/stock/nvax/revenue-from-grants https://stock.noler.com/us/stock/nvax/other-nonoperating-expense https://stock.noler.com/us/stock/nvax/profit-loss https://stock.noler.com/us/stock/nvax/other-comprehensive-income-loss-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/nvax/other-comprehensive-income-loss-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-options-grants-in-period-weighted-average-grant-date-fair-value https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-grants-in-period-weighted-average-grant-date-fair-value https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-vested-in-period-weighted-average-grant-date-fair-value https://stock.noler.com/us/stock/nvax/share-based-compensation-arrangement-by-share-based-payment-award-equity-instruments-other-than-options-forfeitures-weighted-average-grant-date-fair-value https://stock.noler.com/us/stock/nvax/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/nvax/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/nvax/equity-issuance-per-share-amount https://stock.noler.com/us/stock/nvax/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nvax/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/nvax/operating-expenses https://stock.noler.com/us/stock/nvax/severance-costs1 https://stock.noler.com/us/stock/nvax/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/nvax/income-loss-attributable-to-parent https://stock.noler.com/us/stock/nvax/unsolicited-tender-offer-costs https://stock.noler.com/us/stock/nvax/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/nvax/short-term-lease-cost https://stock.noler.com/us/stock/nvax/contract-revenue-cost https://stock.noler.com/us/stock/nvax/debt-issuance-costs https://stock.noler.com/us/stock/nvax/license-costs https://stock.noler.com/us/stock/nvax/amortization-of-intangible-assets https://stock.noler.com/us/stock/nvax/operating-lease-expense https://stock.noler.com/us/stock/nvax/amortization-of-financing-costs https://stock.noler.com/us/stock/nvax/impairment-of-investments https://stock.noler.com/us/stock/nvax/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/nvax/available-for-sale-securities-gross-unrealized-loss https://stock.noler.com/us/stock/nvax/lease-and-rental-expense https://stock.noler.com/us/stock/nvax/operating-leases-rent-expense-net https://stock.noler.com/us/stock/nvax/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net https://stock.noler.com/us/stock/nvax/interest-expense https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/nvax/effective-income-tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/nvax/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/nvax/income-tax-expense-benefit-continuing-operations https://stock.noler.com/us/stock/nvax/stock-issued-during-period-shares-acquisitions https://stock.noler.com/us/stock/nvax/stock-issued-during-period-value-other https://stock.noler.com/us/stock/nvax/adjustments-to-additional-paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/nvax/net-cash-provided-by-used-in-operating-activities-continuing-operations https://stock.noler.com/us/stock/nvax/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/nvax/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/nvax/other-noncash-income https://stock.noler.com/us/stock/nvax/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/nvax/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/nvax/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/nvax/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/nvax/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/nvax/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/nvax/net-cash-provided-by-used-in-investing-activities-continuing-operations https://stock.noler.com/us/stock/nvax/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/nvax/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/nvax/payments-to-acquire-property-plant-and-equipment https://stock.noler.com/us/stock/nvax/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/nvax/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/nvax/payments-to-acquire-businesses-net-of-cash-acquired https://stock.noler.com/us/stock/nvax/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/nvax/net-cash-provided-by-used-in-financing-activities-continuing-operations https://stock.noler.com/us/stock/nvax/proceeds-from-notes-payable https://stock.noler.com/us/stock/nvax/proceeds-from-related-party-debt https://stock.noler.com/us/stock/nvax/proceeds-from-issuance-of-unsecured-debt https://stock.noler.com/us/stock/nvax/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/nvax/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/nvax/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/nvax/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/nvax/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/nvax/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/nvax/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/nvax/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/nvax/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/nvax/payments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/nvax/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/nvax/cash-and-cash-equivalents-period-increase-decrease https://stock.noler.com/us/stock/nvax/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/nvax/cash-acquired-from-acquisition https://stock.noler.com/us/stock/nvax/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/nvax/restructuring-costs https://stock.noler.com/us/stock/nvax/repayment-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/nvax/stock-issued1 https://stock.noler.com/us/stock/nvax/conversion-of-stock-amount-converted1 https://stock.noler.com/us/stock/nvax/adjustments-to-additional-paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/nvax/payments-to-develop-software https://stock.noler.com/us/stock/nvax/interest-paid https://stock.noler.com/us/stock/nvax/income-taxes-paid https://stock.noler.com/us/stock/nvax/commercial-paper-at-carrying-value https://stock.noler.com/us/stock/nvax/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/nvax/security-deposit https://stock.noler.com/us/stock/nvax/restructuring-and-related-cost-number-of-positions-eliminated-inception-to-date-percent https://stock.noler.com/us/stock/nvax/litigation-settlement-amount-awarded-to-other-party https://stock.noler.com/us/stock/nvax/deferred-finance-costs-net https://stock.noler.com/us/stock/nvax/class-of-warrant-or-right-exercise-price-of-warrants-or-rights1 https://stock.noler.com/us/stock/nvax/share-price https://stock.noler.com/us/stock/nvax/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/nvax/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/nvax/business-combination-pro-forma-information-earnings-or-loss-of-acquiree-since-acquisition-date-actual https://stock.noler.com/us/stock/nvax/business-combination-consideration-transferred1 https://stock.noler.com/us/stock/nvax/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/nvax/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/nvax/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/nvax/deductions-charges https://stock.noler.com/us/stock/nvax/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/nvax/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/nvax/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/nvax/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/nvax/increase-decrease-in-fair-value-of-unhedged-derivative-instruments